Ethical Challenges In Biodefense And Bioterrorism | 5421
ISSN: 2157-2526

Journal of Bioterrorism & Biodefense
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ethical challenges in biodefense and bioterrorism

International Conference on Biothreats & Biodefense

John D. Loike and Ruth L. Fischbach

ScientificTracks Abstracts: J Bioterr Biodef

DOI: 10.4172/2157-2526.S1.002

Hidehito Mukai received his Ph.D. degree in Applied Biochemistry from the University of Tsukuba in 1990. He advanced his career by working at UT Southwestern, University of Tsukuba, MITTI-NEDO Project at JT, Mitsubishi Kagaku Institute of Life Sciences, and Kyoto Pharmaceutical University. He is currently Principal Investigator of Laboratory of Peptide Science and Associate Professor of Nagahama Institute of Bio-Science and Technology. His main research interests are the discovery of "cryptides", novel endogenous regulatory peptides hidden in protein structures, and their "accumulative" signaling mechanisms.
Loike is the Co-Director for Graduate Studies in the Department of Physiology Cellular Biophysics and Director of Special Programs in the Center for Bioethics at Columbia University College of Physicians and Surgeons. He serves as course instructor for Frontiers in Bioethics, Ethics for Biomedical Engineers, and Stem Cells: Biology, Ethics, and Applications, at Columbia College. He is director of BioCEP (Bioethical Cross-cultural Educational Program), that is an educational enrichment summer workshop for students and faculty to explore contemporary and contentious bioethical issues in developing countries. His scientific research focuses on how human white blood cells combat infections and cancer.